TriangleNCT02086552 · OUTCOME
Overall Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- years
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Time from SCT to death due to any cause, assessed up to 3 years
What was measured
Overall Survival (OS) is defined as the time from Stem Cell Transplant (SCT) to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier.
Analysis population: All patients that began protocol treatment and were eligible were included in this endpoint.
Groups in this outcome
Treatment (Sonidegib, Lenalidomide)
Patients receive 400 mg sonidegib PO QD on days 1-28 and 10 mg lenalidomide PO QD on days 1-21. Treatment repeats every 28 days for up to 18 courses in the absence of disease progression or unacceptable toxicity.
| Group | Source count |
|---|---|
| Treatment (Sonidegib, Lenalidomide) | 26 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Treatment (Sonidegib, Lenalidomide) | NA | Not reported | 4.3 | NA | Too few events have occurred to estimate the median and upper 95% confidence interval. |
Complete source fields
- classes
- categories
- measurements
- comment
- Too few events have occurred to estimate the median and upper 95% confidence interval.
- group Id
- OG000
- lower Limit
- 4.3
- upper Limit
- NA
- value
- NA
- denoms
- counts
- group Id
- OG000
- value
- 26
- units
- Participants
- description
- Overall Survival (OS) is defined as the time from Stem Cell Transplant (SCT) to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Patients receive 400 mg sonidegib PO QD on days 1-28 and 10 mg lenalidomide PO QD on days 1-21. Treatment repeats every 28 days for up to 18 courses in the absence of disease progression or unacceptable toxicity.
- id
- OG000
- title
- Treatment (Sonidegib, Lenalidomide)
- param Type
- MEDIAN
- population Description
- All patients that began protocol treatment and were eligible were included in this endpoint.
- reporting Status
- POSTED
- time Frame
- Time from SCT to death due to any cause, assessed up to 3 years
- title
- Overall Survival
- type
- SECONDARY
- unit Of Measure
- years
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice